Patent Assignment
Reel/Frame 048459/0617
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded: 2019-02-27
Received: 2019-02-27
Pages: 8
Assignor
MEDIMMUNE, LLC
Executed: 2019-01-23
Assignee
AREXIS AB
--, STOCKHOLM, SEX, SE-112 76, SWEDEN
Covered Applications
(18)
STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
App. No. 15/852,023
→
STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
App. No. 15/041,295
→
ANTIBODIES AGAINST AND METHODS FOR PRODUCING VACCINES FOR RESPIRATORY SYNCYTIAL VIRUS
App. No. 14/797,736
→
STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
App. No. 14/554,804
→
ANTIBODIES AGAINST AND METHODS FOR PRODUCING VACCINES FOR RESPIRATORY SYNCYTIAL VIRUS
App. No. 14/479,612
→
STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
App. No. 13/873,458
→
STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
App. No. 13/481,640
→
ANTIBODIES AGAINST AND METHODS FOR PRODUCING VACCINES FOR RESPIRATORY SYNCYTIAL VIRUS
App. No. 13/147,051
→
STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
App. No. 13/184,455
→
STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
App. No. 12/817,097
→
ANTIBODIES AGAINST AND METHODS FOR PRODUCING VACCINES FOR RESPIRATORY SYNCYTIAL VIRUS
App. No. 12/718,476
→
STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
App. No. 11/906,543
→
STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
App. No. 11/362,267
→
ANTIBODIES AGAINST AND METHODS FOR PRODUCING VACCINES FOR RESPIRATORY SYNCYTIAL VIRUS
App. No. 11/230,593
→
CRYSTALS AND STRUCTURE OF SYNAGIS FAB
App. No. 11/207,142
→
STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
App. No. 10/461,904
→
CRYSTALS AND STRUCTURE OF SYNAGIS FAB
App. No. 10/135,636
→
COMBINATION THERAPY OF RESPIRATORY DISEASES USING ANTIBODIES AND ANTI-INFLAMMATORY AGENTS
App. No. 09/848,377
→